AAP
EBS icon

Arax Advisory Partners’s Emergent Biosolutions EBS Stock Holding History

Arax Advisory Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5K Buy
3,286
+3,141
+2,166% +$26.3K ﹤0.01% 3735
2026
Q1 		$1.2K Buy
145
+109
+303% +$1.13K ﹤0.01% 3249
2025
Q4 		$446 Sell
36
-2,609
-99% -$28K ﹤0.01% 3628
2025
Q3 		$23.3K Buy
+2,645
New +$20.6K ﹤0.01% 2198
2025
Q1 		– Sell
-472
Closed -$4.51K – 2780
2024
Q4 		$4.51K Sell
472
-1,335
-74% -$12.3K ﹤0.01% 1774
2024
Q3 		$15.1K Hold
1,807
– – ﹤0.01% 1212
2024
Q2 		$12.3K Buy
+1,807
New +$7.78K ﹤0.01% 1168

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Arax Advisory Partners's EBS Position: Q2 2026 in Review

Arax Advisory Partners increased its Emergent Biosolutions (EBS) stake by 2,166% in Q2 2026, buying an estimated $26.3K and bringing the position to 3,286 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3735.

Arax Advisory Partners first reported a position in EBS in Q2 2024 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Arax Advisory Partners held 3,286 shares of Emergent Biosolutions worth $27.5K as of Q2 2026.
  • Arax Advisory Partners bought 3,141 Emergent Biosolutions shares in Q2 2026, an estimated $26.3K.
  • Emergent Biosolutions made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3735 holding.
  • Arax Advisory Partners first reported a position in Emergent Biosolutions in Q2 2024 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.